Sign in

You're signed outSign in or to get full access.

Jon Cheigh

President and Chief Investment Officer at COHEN & STEERSCOHEN & STEERS
Executive

About Jon Cheigh

Jon Cheigh, 52, is President and Chief Investment Officer of Cohen & Steers (CNS). He joined CNS in 2005 as a REIT analyst, became a portfolio manager in 2008, was appointed CIO in 2019, and was named President effective January 1, 2025. He holds a BA cum laude from Williams College and an MBA from the University of Chicago . Company performance under the current leadership included 2024 revenues of $517.4M (+5.7% YoY), operating margin of 33.4% (35.4% as adjusted), and diluted EPS of $2.97 ($2.93 as adjusted), alongside strong investment results (95% of portfolios beat benchmarks on 1-year; 96–99% over 3/5/10 years) and a 2024 TSR index value of 175.38 (base $100) .

Company performance snapshot

Metric20232024
Revenues ($M)489.6 517.4
Operating Margin (%)33.6 (36.2 as adjusted) 33.4 (35.4 as adjusted)
Diluted EPS ($)2.60 (2.84 as adjusted) 2.97 (2.93 as adjusted)
TSR Index (start $100)139.71 175.38

Past Roles

OrganizationRoleYearsStrategic impact
Cohen & SteersPresident and Chief Investment Officer2025–presentLeads investment department and executive leadership agenda .
Cohen & SteersChief Investment Officer2019–2024Senior PM for global real estate; strengthened processes and culture .
Cohen & SteersHead of Global Real Estate2012–2023Advanced listed and private real estate strategies .
Cohen & SteersPortfolio Manager2008–presentSenior PM for all global real estate strategies .
Cohen & SteersREIT Analyst2005–2008Coverage and research underpinning real assets platform .
Security Capital Research & ManagementVP, Senior REIT Analystpre-2005Buy-side REIT research expertise .
InterParkVP, Real Estate Acquisitionspre-2005Direct real estate transaction experience .
Urban Growth Property TrustAcquisitions Associatepre-2005Private real estate acquisitions experience .

Fixed Compensation

Metric202220232024
Base Salary ($)375,000 375,000 375,000
Target Bonus (%)Not disclosed Not disclosed Not disclosed
Cash Bonus Paid ($)3,345,000 2,865,000 3,345,000
All Other Compensation ($)170,113 (incl. 401k match; dividend equivalents) 189,186 (incl. 401k match; dividend equivalents) 199,035 (incl. 401k match; dividend equivalents)

Notes:

  • CNS uses discretionary, holistic assessments rather than formulaic targets or weightings for annual incentives .
  • Executives receive standard employee benefits (401k with match; ESPP) and are prohibited from hedging CNS stock .

Performance Compensation

ComponentYearStructureWeightingTargetActualPayoutVesting
Annual performance incentives (cash)2022Discretionary, based on financial, investment, strategic objectives Not disclosed Not disclosed Not disclosed $3,345,000 N/A
Annual performance incentives (cash)2023Discretionary Not disclosed Not disclosed Not disclosed $2,865,000 N/A
Annual performance incentives (cash)2024Discretionary Not disclosed Not disclosed Not disclosed $3,345,000 N/A
Mandatory RSU deferral (part of annual incentives)2022RSUs in lieu of cash; deferral % at committee discretionNot disclosed N/AN/A$2,480,000 Ratably over 4 years; dividends accrue as RSUs vesting on last tranche
Mandatory RSU deferral2023Same as aboveNot disclosed N/AN/A$2,160,000 4-year ratable; dividends accrue
Mandatory RSU deferral2024Same as aboveNot disclosed N/AN/A$2,480,000 4-year ratable; dividends accrue
RSU grant for 2023 performanceGranted 1/31/202430,127 RSUs; grant-date FV $2,159,955 N/AN/AN/AN/AVests ratably last business day of Jan 2025–2028; dividends accrue and vest on last date

Additional points:

  • For 2024, the Committee increased Cheigh’s total compensation by 14.8% vs. 2023; 94.0% of his 2024 total comp was performance incentives, with 40% deferred in RSUs .
  • CNS does not currently grant stock options or similar awards .

Equity Ownership & Alignment

  • Beneficial ownership (as of March 6, 2025): 86,835 shares of common stock; RSUs held: 80,910; ownership <1% of outstanding .
  • Unvested RSUs at FY-end (12/31/2024): 85,903 units (includes 7,675 unvested dividend equivalents), market value $7,932,283 at $92.34/share .
  • Ownership guidelines: CNS does not maintain formal stock ownership guidelines for executives given significant insider ownership; hedging of CNS securities is prohibited .
Ownership detailAs ofValue/Count
Beneficially owned shares03/06/202586,835 shares (<1%)
RSUs held (non-voting)03/06/202580,910 units
Unvested RSUs (market value)12/31/202485,903 units; $7,932,283 value @ $92.34

Alignment and pledging:

  • No disclosure of any pledged Cheigh shares; company policy prohibits hedging; insider trading governed by policy with preclearance/blackouts .

Employment Terms

  • Agreements: No separate employment agreement for Cheigh disclosed; incentive awards governed by CNS Amended & Restated Stock Incentive Plan .
  • Change-in-control (CIC): Double-trigger accelerated vesting of unvested RSUs if terminated without cause or resigns for good reason within 2 years post-CIC; also accelerates upon death or disability .
  • Potential payout proxy values (as of 12/31/2024): Accelerated RSU vesting of $7,932,283 upon qualifying CIC termination or death/disability (based on $92.34/share) .
Scenario (as of 12/31/2024)Estimated value
Termination without cause or resignation for good reason within 2 years post-CIC$7,932,283 (accelerated RSUs)
Death or disability$7,932,283 (accelerated RSUs)

Key definitions: “Cause,” “Good Reason,” “Change in Control,” and “Disability” are defined in award agreements as summarized in the proxy .

Insider Trading and Vesting/Selling Pressure

Recent Form 4 activity indicates periodic sales around vesting cycles:

  • 05/22/2024: Sold 7,159 shares at $72.57; proceeds ≈ $519,529 .
  • 07/25/2024: Sold 12,500 shares at $84.08; proceeds ≈ $1,050,988 .
  • 05/09/2025: Sold 25,500 shares at $80.01; proceeds ≈ $2,040,255 .

Additional RSU accruals:

  • Dividend equivalent RSUs periodically accrue on unvested RSUs (e.g., 2025Q2 accruals reported for executives) and vest with the final tranche, supporting ongoing supply near vest dates .

Implication: Mandatory 4-year ratable vesting on late-January schedules (plus mid-year accruals) creates repeatable windows for potential insider liquidity; however, Cheigh retains a substantial position and continues to receive deferred equity, aligning longer-term incentives .

Performance & Track Record

  • 2024 impact: Delivered strong investment performance relative to benchmarks; advanced listed and private real estate strategies; strengthened processes and succession planning; partnered on corporate strategy and growth initiatives .
  • 2023 impact: Demonstrated leadership; improved select strategy performance; progressed succession and hiring plans; advanced listed/private real estate processes .
  • Say-on-Pay support: 93.55% approval in most recent vote, signaling shareholder support for pay practices .
  • Pay vs performance linkage: Company discloses “compensation actually paid” and TSR peers; 2024 TSR index at 175.38 vs peer group 257.30; Operating Income (as adjusted) used as company-selected measure .

Compensation Structure Analysis

  • Mix and deferral: High proportion of at-risk, performance-linked compensation; significant mandatory equity deferral for senior executives enhances retention and alignment (Cheigh: 94% of 2024 comp was performance incentives; 40% deferred) .
  • No options; time-vested RSUs: CNS does not grant options; RSUs vest over four years with dividend equivalents accruing; no PSU framework disclosed (reduces performance-risk asymmetry but strengthens retention) .
  • Discretionary framework: No preset weightings/targets; Committee balances investment results, financial outcomes (including “as adjusted” metrics), strategic progress, talent and culture .

Multi-Year Compensation (Committee view; performance-year basis)

Metric202220232024
Base Salary ($)375,000 375,000 375,000
Cash Bonus ($)3,345,000 2,865,000 3,345,000
Mandatory RSU Deferral ($)2,480,000 2,160,000 2,480,000
Total ($)6,200,000 5,400,000 6,200,000

Note: SEC Summary Compensation Table differs in timing (reports grant-date FV when granted); the table above ties compensation to performance year, consistent with committee discussion .

Equity Grants and Outstanding Awards

DetailValue
2024 RSU grant for 2023 performance30,127 RSUs; $2,159,955 grant-date FV (granted 1/31/2024)
Vesting scheduleRatable on last business day of Jan 2025–2028; dividend equivalents accrue and vest at final tranche
Unvested RSUs at FY-end 202485,903 RSUs (incl. 7,675 dividend equivalents), market value $7,932,283 @ $92.34

Governance and Policies Relevant to Incentives

  • Clawback: NYSE/Rule 10D-1 compliant recoupment policy; mandatory recovery of erroneously awarded incentive-based compensation after restatements on a no-fault basis .
  • Hedging/short sales: Prohibited for directors and employees .
  • Ownership guidelines: No formal guidelines; rationale is high insider ownership; founders control significant stakes (context for governance; not specific to Cheigh) .

Investment Implications

  • Alignment: High share of at-risk pay and multi-year RSU vesting tie Cheigh’s outcomes to long-term investment and financial performance; no options or PSUs reduces performance-leverage but strengthens retention via time-based equity .
  • Liquidity windows: Mandatory deferral and January vesting create recurring supply; observed 2024–2025 insider sales suggest potential near-term selling pressure around vesting, though Cheigh maintains sizable holdings and ongoing equity accruals .
  • Retention and succession: 2024 Committee commentary highlights succession execution and talent pipeline; equity deferrals support retention in the investment franchise .
  • CIC risk/reward: Double-trigger RSU acceleration yields meaningful value in a change-in-control termination, aligning incentives in strategic events while avoiding single-trigger windfalls .
  • Shareholder posture: Strong Say-on-Pay support (93.55%) indicates investor acceptance of the discretionary, equity-heavy design, though absence of formal ownership guidelines is atypical among peers .